New Therapeutics for Extracellular Vesicles: Delivering CRISPR for Cancer Treatment
Cancers are defined by genetic defects, which underlines the prospect of using gene therapy in patient care. During the past decade, CRISPR technology has rapidly evolved into a powerful gene editing tool with high fidelity and precision. However, one of the impediments slowing down the clinical tra...
Main Authors: | Biying Yan, Yaxuan Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/24/15758 |
Similar Items
-
CRISPR delivery with extracellular vesicles: Promises and challenges
by: Anne Højberg Berggreen, et al.
Published: (2023-09-01) -
Engineered Cas9 extracellular vesicles as a novel gene editing tool
by: Xabier Osteikoetxea, et al.
Published: (2022-05-01) -
Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
by: Xiaowen Huang, et al.
Published: (2023-06-01) -
Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool
by: Tianwen Li, et al.
Published: (2023-04-01) -
Engineered extracellular vesicles for delivering functional Cas9/gRNA to eliminate hepatitis B virus cccDNA and integration
by: Wanjia Zeng, et al.
Published: (2024-12-01)